Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) vs Somalia: Prevalence of anemia among women of reproductive age

Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
36.5%
in 2023
Somalia
46.2%
in 2023
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank
14th
Somalia rank
12th

Prevalence of anemia among women of reproductive age over time

  • Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
  • Somalia
01020304050200020112023

How they compare

Somalia currently reports 46.2% against 36.5% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 9.7%.

That makes Somalia's figure about 1.3 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.

Across all 24 years both countries report, Somalia has been ahead every year.

Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 14th and Somalia ranks 12th of 47 groups.

Somalia has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) Somalia Difference Ahead
2000s 32.6% 43.2% 10.6% Somalia
2010s 34.0% 43.0% 8.9% Somalia
2020s 35.7% 45.5% 9.7% Somalia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence of anemia among women of reproductive age, Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) or Somalia?
Somalia, at 46.2% against 36.5% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2023.
What is the difference in prevalence of anemia among women of reproductive age between Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Somalia?
9.7%, with Somalia ahead.
How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Somalia?
24 years are reported by both, from 2000 to 2023.
How do Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Somalia rank globally for prevalence of anemia among women of reproductive age?
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 14th and Somalia ranks 12th of 47 groups.
Where does this data come from?
Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) vs Somalia: Prevalence of anemia among women of reproductive age. Statizoid, drawing on Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO). Retrieved 18 September 2026, from https://health.statizoid.com/compare/prevalence-of-anemia-among-women-of-reproductive-age-percent-of-women-ages-15-49/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/somalia-fed-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/prevalence-of-anemia-among-women-of-reproductive-age-percent-of-women-ages-15-49/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/somalia-fed-rep/">Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) vs Somalia: Prevalence of anemia among women of reproductive age</a> — Statizoid

About this data

Indicator
Prevalence of anemia among women of reproductive age (% of women ages 15-49)
Unit
% of women ages 15-49
Source
Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
239 places, 5,736 data points, 2000–2023
Last refreshed

Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.